D-0287-2021 Class II Terminated
FDA drug recall D-0287-2021 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 17, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 21, 2022). Affected quantity: a) 1350 bottles; b) 147 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 3, 2021
- Initiation Date
- Feb 17, 2021
- Termination Date
- Dec 21, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 1350 bottles; b) 147 cartons
Product description
Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA
Code information
Lot #: a) H2000206, Exp 06/22; b) H2000138, Exp 06/22
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0287-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026